- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Part B: CR845 1.0 mcg/kg
Total 184 results
-
Cara Therapeutics, Inc.CompletedPruritus | Uremic PruritusUnited States
-
Cara Therapeutics, Inc.CompletedUremic PruritusUnited States, Czechia, Hungary, Poland
-
Cara Therapeutics, Inc.CompletedUremic PruritusUnited States, Canada, Czechia, Australia, Germany, Hungary, Korea, Republic of, New Zealand, Poland, Taiwan, United Kingdom
-
Cara Therapeutics, Inc.CompletedUremic PruritusUnited States
-
Cara Therapeutics, Inc.Completed
-
Protalex, Inc.CompletedArthritis, RheumatoidUnited States
-
Cara Therapeutics, Inc.CompletedUremic PruritusUnited States
-
Cara Therapeutics, Inc.CompletedPost Abdominal Surgery PainUnited States
-
Janssen Pharmaceutical K.K.Completed
-
Cara Therapeutics, Inc.Terminated
-
Chong Kun Dang PharmaceuticalCompletedType2 Diabetes MellitusKorea, Republic of
-
Cara Therapeutics, Inc.Completed
-
Cara Therapeutics, Inc.Completed
-
Cara Therapeutics, Inc.RecruitingPruritus | Notalgia ParestheticaUnited States, Poland, Spain, Canada, Germany
-
Huahui HealthCompleted
-
University of Texas Southwestern Medical CenterGlaxoSmithKlineRecruitingAL Amyloidosis | AmyloidosisUnited States
-
Stealth BioTherapeutics Inc.CompletedFuchs' Corneal Endothelial Dystrophy (FCED)United States
-
Yonsei UniversityCompletedAnesthesia, GeneralKorea, Republic of
-
Cara Therapeutics, Inc.CompletedPruritus | Atopic DermatitisUnited States, Canada
-
GangaGen, Inc.CompletedBacterial Infections | Infectious DiseaseSingapore
-
PfizerTerminatedMultiple SclerosisUnited States
-
GlaxoSmithKlineTerminatedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom
-
AstraZenecaCompletedCardiovascular Disease | Healthy Male SubjectsUnited Kingdom
-
Eisai Inc.BiogenActive, not recruitingAlzheimer's DiseaseUnited States, Canada, France, Germany, Italy, Japan, Korea, Republic of, Netherlands, Spain, Sweden, United Kingdom
-
EMD SeronoMerck KGaA, Darmstadt, GermanyTerminated
-
Human Genome Sciences Inc.CompletedLupus Erythematosus, SystemicUnited States, Canada
-
Dompé Farmaceutici S.p.ACovanceCompletedHealthySwitzerland, United Kingdom
-
Human Genome Sciences Inc.GlaxoSmithKlineCompletedSystemic Lupus ErythematosusHong Kong, Taiwan, Korea, Republic of, India, Chile, Argentina, Philippines, Colombia, Brazil, Romania, Australia, Peru, Russian Federation
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Terminated
-
Novo Nordisk A/SCompletedHealthy Volunteers - Haemophilia AGermany
-
MedImmune LLCCambridge Antibody TechnologyTerminatedLeukemia, Lymphoma, Chronic Lymphocytic | Leukemia, Prolymphocytic Leukemia, Small | Lymphocytic Lymphoma, Moxetumomab PasudotoxUnited States, Poland
-
Baylor College of MedicineCompletedPost Operative Analgesia | Pediatric AdenotonsillectomyUnited States
-
Novartis PharmaceuticalsCompletedHypertensionSweden, Belgium, Hungary, India, Italy, Poland, Turkey, United States, Brazil, France, South Africa
-
Praxis Precision MedicinesRecruitingSCN2A Encephalopathy | SCN8A EncephalopathyUnited States, Spain
-
Janssen R&D IrelandCompleted
-
Praxis Precision MedicinesPraxis Precision Medicines Australia Pty LtdCompletedEssential TremorUnited States, Australia, New Zealand
-
Pontificia Universidade Catolica de Sao PauloNot yet recruitingNeuromuscular Blockade | Neuromuscular Block, Residual | Neuromuscular Block Prolonged
-
MediBeaconCompleted
-
Human Genome Sciences Inc.GlaxoSmithKlineCompletedSystemic Lupus ErythematosusUnited States, Spain, Israel, Netherlands, Canada, Germany, Poland, Romania, Puerto Rico, Costa Rica, Belgium, Slovakia, United Kingdom, Mexico, Italy, Austria, Czech Republic, Sweden, France
-
Insel Gruppe AG, University Hospital BernRecruitingAntifibrinolytic AgentsSwitzerland
-
AstraZenecaCompletedAsthma (Part 1) | COPD (Part 2)United Kingdom
-
Healthgen Biotechnology Corp.RecruitingEmphysema Secondary to Congenital AATDUnited States
-
EMD SeronoTerminatedCarcinoma, Non-Small-Cell LungUnited States, Germany
-
Attikon HospitalAHEPA University Hospital; University Hospital, AlexandroupolisCompleted
-
Ludwig Institute for Cancer ResearchDaiichi Sankyo Co., Ltd.; Austin HealthCompletedMalignant Solid Tumor | Metastatic EphA2 Positive CancerAustralia
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Alexion PharmaceuticalsTerminatedAcute Graft-Versus-Host Disease | GIGVHDUnited States, France
-
Centocor Research & Development, Inc.CompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous
-
University of Texas Southwestern Medical CenterCompletedHepatocellular Carcinoma | Liver CancerUnited States
-
Flame BiosciencesWithdrawnGastric Cancer | Solid Tumor | Pancreas Cancer